SCHEMBL671675

SCHEMBL671675

C=C(C)C(=O)OC(C)SCCSC(C)OC(=O)C(=C)C

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.39
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL673042 0.94 TSHR (0.41) TSHRALDH1A1THRB
SCHEMBL10427135 0.92 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL10427162 0.92 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL2432692 0.87 TSHR (0.43) TSHRALDH1A1THRB
SCHEMBL1695697 0.86 TSHR (0.44) TSHRALDH1A1THRB
SCHEMBL670914 0.85 TSHR (0.40) TSHRALDH1A1THRB
SCHEMBL7646476 0.84 TSHR (0.49) TSHRTHRB
SCHEMBL7259440 0.81 TSHR (0.40) TSHRALDH1A1THRB
SCHEMBL491118 0.80 TSHR (0.45) TSHRALDH1A1THRB
SCHEMBL2430676 0.78 TSHR (0.43) TSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194511-B1 COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND TOKUYAMA CORPORATION (JP) 2001-02-27 US claimed
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-05-21 US disclosed
EP-3901185-B1 CURABLE COMPOSITION FOR OPTICAL MATERIALS, AND OPTICAL MATERIAL TOKUYAMA CORP (JP) 2026-03-25 EP disclosed
EP-4696722-A1 (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2026-02-18 EP disclosed
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article TOKUYAMA CORPORATION (JP) 2026-02-17 US disclosed
EP-4644435-A1 URETHANE (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENSES, AND EYEGLASSES TOKUYAMA CORPORATION (JP) 2025-11-05 EP disclosed
EP-4636466-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-10-22 EP disclosed
EP-4636465-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-10-22 EP disclosed
EP-4636464-A1 CURABLE COMPOSITION, CURED BODY, LAMINATE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-10-22 EP disclosed
US-12428517-B2 Moisture curable polyurethane composition and laminate TOKUYAMA CORPORATION (JP) 2025-09-30 US disclosed
US-8066917-B2 Photochromic curable composition TOKUYAMA CORPORATION (JP) 2011-11-29 US disclosed
US-20100230650-A1 PHOTOCHROMIC CURABLE COMPOSITION GULFSTREAM INC. (CA) 2010-09-16 US disclosed
EP-2221325-A1 PHOTOCHROMIC CURABLE COMPOSITION Tokuyama Corporation (JP) 2010-08-25 EP disclosed
EP-1130038-B1 PHOTOCHROMIC CURABLE COMPOSITION TOKUYAMA CORP (JP) 2009-05-06 EP disclosed
US-20050263745-A1 Method of preparing a ceramic artificial crown and a preparation kit used therefor TOKUYAMA CORPORATION (JP) 2005-12-01 US disclosed
EP-0940694-B1 Photochromic curable composition TOKUYAMA CORP (JP) 2002-08-14 EP disclosed
EP-1130038-A1 CURABLE COMPOSITION TOKUYAMA CORPORATION (JP) 2001-09-05 EP disclosed
US-6194511-B1 COMPRISING POLYMERIZABLE MONOMER CONTAINING SULFUR-CONTAINING (METH)ACRYLATE POLYMERIZABLE MONOMER AND PHOTOCHROMIC COMPOUND TOKUYAMA CORPORATION (JP) 2001-02-27 US disclosed
EP-0940694-A1 Photochromic curable composition TOKUYAMA CORPORATION (JP) 1999-09-08 EP disclosed
US-4939218-A Sulfur-containing aliphatic acrylic compound, crosslinked polymer article, and lens MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1990-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article C5, SCO2, ZYX TSHR 3533/4885ALDH1A1 1308/4885THRB 2158/4885
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES CRYAA, FEM1B, MAPRE1 TSHR 4218/4885ALDH1A1 588/4885THRB 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.